2854 Federal Register / Vol. 79, No. 11 / Thursday, January 16, 2014 / Notices 

the current ONC–AA (ANSI). 

Accordingly, this notice is issued 

pursuant to § 170.503(b), which requires 

the National Coordinator for Health 

Information Technology (the National 

Coordinator) to publish a notice in the 

Federal Register to announce the 30-day 

period during which requests for ONC– 

AA status may be submitted. In order to 

be considered for ONC–AA status, an 

accreditation organization must submit 

a written request to the National 

Coordinator that includes the 

information required by § 170.503(b) 

within the 30-day period specified in 

this notice. Section 170.503(b) requires 

an accreditation organization to submit 

the following information to 

demonstrate its ability to serve as an 

ONC–AA: 

(1) A detailed description of the 

accreditation organization’s 

conformance to ISO/IEC17011:2004 

(incorporated by reference in § 170.599) 

and experience evaluating the 

conformance of certification bodies to 

ISO/IEC Guide 65:1996 (incorporated by 

reference in § 170.599); 

(2) A detailed description of the 

accreditation organization’s 

accreditation requirements[,] as well as 

how those requirements would 

complement the Principles of Proper 

Conduct for ONC–ACBs and ensure the 

surveillance approaches used by ONC– 

ACBs include the use of consistent, 

objective, valid, and reliable methods; 

(3) Detailed information on the 

accreditation organization’s procedures 

that would be used to monitor ONC– 

ACBs; 

(4) Detailed information, including 

education and experience, about the key 

personnel who review organizations for 

accreditation; and 

(5) Procedures for responding to, and 

investigating, complaints against ONC– 

ACBs. 

Requests for ONC–AA status may be 

submitted by email to ONC–AA@

hhs.gov and should include ‘‘Request 

for ONC–AA Status’’ in the subject line. 

Alternatively, requests for ONC–AA 

status may be submitted by regular or 

express mail to: Office of the National 

Coordinator for Health Information 

Technology, Attention: ONC HIT 

Certification Program—Request for 

ONC–AA Status, 330 C Street SW., 

Washington, DC 20201. In accordance 

with § 170.505, the official date of 

receipt of an email submission will be 

the date on which it was sent, and the 

official date of a submission by regular 

or express mail will be the date of the 

delivery confirmation. To clarify, email 

submissions may be sent up to and 

through 11:59 p.m. on the last day of the 

submission period. Additional 

information about requesting ONC–AA 

status and the ONC HIT Certification 

Program can be found on the ONC Web 

site at: http://healthit.hhs.gov/

certification. 

Dated: January 10, 2014. 

Jacob Reider, 

Acting National Coordinator for Health 

Information Technology. 

[FR Doc. 2014–00797 Filed 1–15–14; 8:45 am] 

BILLING CODE 4150–45–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket Number CDC–2014–0002; NIOSH 

248–A] 

World Trade Center Health Program 

Scientific/Technical Advisory 

Committee (WTCHP STAC or Advisory 

Committee), National Institute for 

Occupational Safety and Health 

(NIOSH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Time and Date: 9:30 a.m.–5:00 p.m., 

February 14, 2014 (All times are Eastern 

Standard Time) 

Place: This meeting will be available 

via telephone and Web Conference. 

Audio will be available by telephone 

and visuals will be available by Web 

Conference. The USA toll-free, dial-in 

number is 1 (888) 381–5771. To be 

connected to the meeting, you will need 

to provide the following participant 

code to the operator: 8501294. To obtain 

further instructions on how to access 

the meeting online through Web 

Conference, see the instructions at the 

Committee’s meeting Web site: http://

www.cdc.gov/wtc/stac_meeting.html. 

Public Comment Time and Date: 

11:30 a.m.–12:15 p.m., February 14, 

2014. 

Please note that the public comment 

period ends at the time indicated above 

or following the last call for comments, 

whichever is earlier. Members of the 

public who want to comment must sign 

up by providing their name by mail, 

email, or telephone, at the addresses 

provided below, by February 10, 2014. 

Each commenter will be provided up to 

five minutes for comment. A limited 

number of time slots are available and 

will be assigned on a first come-first 

served basis. Written comments will 

also be accepted from those unable to 

attend the public session. 

Status: Open to the public, limited 

only by the number of telephone lines. 

The conference line will accommodate 

up to 100 callers; therefore it is 

suggested that those interested in calling 

in to listen to the committee meeting 

share a line when possible. 

Background: The Advisory Committee 

was established by Public Law 111–347 

(The James Zadroga 9/11 Health and 

Compensation Act of 2010, Title XXXIII 

of the Public Health Service Act), 

enacted on January 2, 2011 and codified 

at 42 U.S.C. sec. 300mm–300mm–61. 

Purpose: The purpose of the Advisory 

Committee is to review scientific and 

medical evidence and to make 

recommendations to the World Trade 

Center (WTC) Program Administrator 

regarding additional WTC Health 

Program eligibility criteria and potential 

additions to the list of covered WTCrelated health conditions. Title XXXIII 

of the Public Health Service Act 

established within the Department of 

Health and Human Services (HHS), the 

World Trade Center (WTC) Health 

Program, to be administered by the WTC 

Program Administrator. The WTC 

Health Program provides: (1) Medical 

monitoring and treatment benefits to 

eligible emergency responders and 

recovery and cleanup workers 

(including those who are Federal 

employees) who responded to the 

September 11, 2001, terrorist attacks, 

and (2) initial health evaluation, 

monitoring, and treatment benefits to 

residents and other building occupants 

and area workers in New York City, who 

were directly impacted and adversely 

affected by such attacks (‘‘survivors’’). 

Certain specific activities of the WTC 

Program Administrator are reserved to 

the Secretary, HHS, to delegate at her 

discretion; other WTC Program 

Administrator duties not explicitly 

reserved to the Secretary, HHS, are 

assigned to the Director, NIOSH. The 

administration of the Advisory 

Committee established under Section 

300mm–1(a) is left to the Director of 

NIOSH in his role as WTC Program 

Administrator. CDC and NIOSH provide 

funding, staffing, and administrative 

support services for the Advisory 

Committee. The charter was reissued on 

May 9, 2013, and will expire on May 9, 

2015. 

Matters To Be Discussed: The agenda 

for the Advisory Committee meeting 

includes a brief update on the policies 

and regulations developed by the WTC 

Health Program and development of 

recommendations for research. 

The agenda is subject to change as 

priorities dictate. 

To view the notice, visit http://

www.regulations.gov and enter CDC– 


ehiers on DSK2VPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 11 / Thursday, January 16, 2014 / Notices 2855 

2014–0002 in the search field and click 

‘‘Search.’’ 

Public Comment Sign-up and 

Submissions to the Docket: To sign up 

to provide public comments or to 

submit comments to the docket, send 

information to the NIOSH Docket Office 

by one of the following means: 

Mail: NIOSH Docket Office, Robert A. 

Taft Laboratories, MS–C–34, 4676 

Columbia Parkway, Cincinnati, Ohio 

45226. 

Email: nioshdocket@cdc.gov. 

Telephone: (513) 533–8611. 

In the event an individual cannot 

attend, written comments may be 

submitted. The comments should be 

limited to two pages and submitted 

through http://www.regulations.gov by 

February 10, 2014. Efforts will be made 

to provide the two-page written 

comments received by the deadline 

below to the committee members before 

the meeting. Comments in excess of two 

pages will be made publicly available at 

http://www.regulations.gov. To view 

background information and previous 

submissions go to NIOSH docket http:// 

www.cdc.gov/niosh/docket/archive/

docket248.html. 

Policy on Redaction of Committee 

Meeting Transcripts (Public Comment): 

Transcripts will be prepared and posted 

to http://www.regulations.gov within 60 

days after the meeting. If a person 

making a comment gives his or her 

name, no attempt will be made to redact 

that name. NIOSH will take reasonable 

steps to ensure that individuals making 

public comments are aware of the fact 

that their comments (including their 

name, if provided) will appear in a 

transcript of the meeting posted on a 

public Web site. Such reasonable steps 

include a statement read at the start of 

the meeting stating that transcripts will 

be posted and names of speakers will 

not be redacted. If individuals in 

making a statement reveal personal 

information (e.g., medical information) 

about themselves, that information will 

not usually be redacted. The CDC 

Freedom of Information Act coordinator 

will, however, review such revelations 

in accordance with the Freedom of 

Information Act and, if deemed 

appropriate, will redact such 

information. Disclosures of information 

concerning third party medical 

information will be redacted. 

Contact Person For More Information: 

Paul J. Middendorf, Ph.D., Designated 

Federal Officer, NIOSH, CDC, 2400 

Century Parkway NE., Mail Stop E–20, 

Atlanta, Georgia 30345, telephone 1 

(888) 982–4748; email: wtc-stac@

cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

Notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention, and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2014–00715 Filed 1–15–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Occupational Safety and 

Health Education and Research Centers 

(ERC) PAR 10–217, initial review. 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Times and Dates: 

6:00 p.m.–7:00 p.m., February 24, 2014 

(Closed) 

8:00 a.m.–5:00 p.m., February 25, 2014 

(Closed) 

8:00 a.m.–5:00 p.m., February 26, 2014 

(Closed) 

8:00 a.m.–12:00 p.m., February 27, 2014 

(Closed) 

Place: Courtyard Marriott, 130 

Clairemont Drive, Decatur, Georgia 

30030, Telephone: (404) 371–0204. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 

552b(c)(4) and (6), Title 5 U.S.C., and 

the Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters To Be Discussed: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Occupational Safety and Health 

Education and Research Centers (ERC) 

PAR 10–217’’. 

Contact Person For More Information: 

George Bockosh, M.S., Scientific Review 

Officer, CDC/NIOSH, 626 Cochrans Mill 

Road, Mailstop P–05, Pittsburgh, 

Pennsylvania 15236, Telephone: (412) 

386–6465 and Joan F. Karr, Ph.D., 

Scientific Review Officer, CDC/NIOSH 

1600 Clifton Road NE., Mailstop E–74, 

Atlanta, Georgia 30333, Telephone: 

(404) 498–2506. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2014–00714 Filed 1–15–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention (CDC) 

Request for Nominations of 

Candidates To Serve on the Advisory 

Committee on Breast Cancer in Young 

Women 

The Centers for Disease Control and 

Prevention (CDC) is soliciting 

nominations for possible membership 

on the Advisory Committee on Breast 

Cancer in Young Women (ACBCYW). 

The Committee provides advice and 

guidance to the Secretary, HHS; the 

Assistant Secretary for Health; and the 

Director, CDC, regarding the formative 

research, development, implementation 

and evaluation of evidence-based 

activities designed to prevent breast 

cancer (particularly among those at 

heightened risk) and promote the early 

detection and support of young women 

who develop the disease. The advice 

provided by the Committee will assist in 

ensuring scientific quality, timeliness, 

utility, and dissemination of credible 

appropriate messages and resource 

materials. 

Nominations are being sought for 

individuals who have expertise and 

qualifications necessary to contribute to 

the accomplishments of the committee’s 

objectives. 

The Secretary, HHS, acting through 

the Director, CDC, shall appoint to the 

advisory committee nominees with 

expertise in breast cancer, disease 

prevention, early detection, diagnosis, 

public health, social marketing, genetic 

screening and counseling, treatment, 

rehabilitation, palliative care, and 

survivorship in young women, or in 

related disciplines with a specific focus 

on young women. Members may be 

invited to serve for up to four years. The 

next cycle of selection of candidates 


ehiers on DSK2VPTVN1PROD with NOTICES